{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:46:22Z","timestamp":1793724382768,"version":"4.6.1"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","award":["1034713"],"award-info":[{"award-number":["1034713"]}],"id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.msard.2024.105943","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T22:14:16Z","timestamp":1729376056000},"page":"105943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review"],"prefix":"10.1016","volume":"92","author":[{"given":"Hanna A.","family":"Frank","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tremlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyla A.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fardowsa","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-2871","authenticated-orcid":false,"given":"Mohammad Ehsanul","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2024.105943_bib0001","doi-asserted-by":"crossref","first-page":"104731","DOI":"10.1016\/j.msard.2023.104731","article-title":"Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis","volume":"75","author":"Abbadessa","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0002","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.pdpdt.2022.103169","article-title":"Restless legs syndrome in multiple sclerosis is related to retinal thinning","volume":"40","author":"Akmaz","year":"2022","journal-title":"Photodiagnosis. Photodyn. Ther."},{"key":"10.1016\/j.msard.2024.105943_bib0003","first-page":"3","article-title":"Cognitive and depressive disorders in multiple sclerosis","volume":"48","author":"Alajbegovic","year":"2009","journal-title":"Acta Clinica Croatica, Supplement"},{"key":"10.1016\/j.msard.2024.105943_bib0004","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3889\/oamjms.2019.283","article-title":"Sexual Function in Iranian Female Multiple Sclerosis Patients","volume":"7","author":"Alehashemi","year":"2019","journal-title":"Open. Access. Maced. J. Med. Sci."},{"key":"10.1016\/j.msard.2024.105943_bib0005","doi-asserted-by":"crossref","first-page":"1195101","DOI":"10.3389\/fpsyt.2023.1195101","article-title":"The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in saudi arabia: a cross-sectional multicentered study","volume":"14","author":"Alswat","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.msard.2024.105943_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000527673","article-title":"Influence of cardiovascular risk factors in early relapsing-remitting multiple sclerosis: a retrospective analysis","volume":"86","author":"Arroyo-Pereiro","year":"2023","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0007","first-page":"889","article-title":"Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex","volume":"52","author":"Askari","year":"2014","journal-title":"Acta Med. Iran."},{"key":"10.1016\/j.msard.2024.105943_bib0008","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1352458506070960","article-title":"Impact of depression and disability on quality of life in iranian patients with multiple sclerosis","volume":"13","author":"Ayatollahi","year":"2007","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0009","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s10072-019-03971-8","article-title":"Impact of opium dependency on clinical and neuropsychological indices of multiple sclerosis patients","volume":"40","author":"Ayoobi","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105943_bib0010","first-page":"204","article-title":"The prevalence of psychiatric disorders in patients with multiple sclerosis in Saudi Arabia","volume":"29","author":"Baeshen","year":"2023","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2024.105943_bib0011","doi-asserted-by":"crossref","first-page":"104966","DOI":"10.1016\/j.msard.2023.104966","article-title":"Multiple sclerosis and quality of life: the role of cognitive impairment on quality of life in people with multiple sclerosis","volume":"79","author":"Bergmann","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0012","doi-asserted-by":"crossref","first-page":"E2216","DOI":"10.1212\/WNL.0000000000008617","article-title":"Disability worsening among persons with multiple sclerosis and depression: a swedish cohort study","volume":"93","author":"Binzer","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0013","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0000000000000768","article-title":"Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity","volume":"83","author":"Browne","year":"2014","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0014","doi-asserted-by":"crossref","first-page":"e0158978","DOI":"10.1371\/journal.pone.0158978","article-title":"Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study","volume":"11","author":"Bsteh","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2024.105943_bib0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/arclin\/acy067","article-title":"Cognitive reserve attenuates the effect of disability on depression in multiple sclerosis","volume":"34","author":"Cadden","year":"2019","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.msard.2024.105943_bib0016","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic. Dis."},{"key":"10.1016\/j.msard.2024.105943_bib0017","doi-asserted-by":"crossref","first-page":"102042","DOI":"10.1016\/j.msard.2020.102042","article-title":"Anxiety in Argentinian patients with multiple sclerosis: prevalence and associated factors","volume":"41","author":"Chertcoff","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0018","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/ene.13821","article-title":"Epilepsy and associated mortality in patients with multiple sclerosis","volume":"26","author":"Chou","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2013.07.003","article-title":"A 10-year follow-up of a population-based study of people with multiple sclerosis in stockholm, sweden: changes in disability and the value of different factors in predicting disability and mortality","volume":"332","author":"Chruzander","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2024.105943_bib0020","doi-asserted-by":"crossref","first-page":"102565","DOI":"10.1016\/j.msard.2020.102565","article-title":"Prevalence of comorbidities in multiple sclerosis and impact on physical disability according to disease phenotypes","volume":"46","author":"Ciampi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0021","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"Coles","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0022","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ncl.2023.06.007","article-title":"Health, wellness, and the effect of comorbidities on the multiple sclerosis disease course","volume":"42","author":"Conway","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2024.105943_bib0023","article-title":"Patterns of comorbidity and multimorbidity among patients with multiple sclerosis in a large US commercially insured and medicare advantage population","volume":"9","author":"Dai","year":"2022","journal-title":"J. Health Econ. Outcomes. Res."},{"key":"10.1016\/j.msard.2024.105943_bib0024","series-title":"Rapid Review Guidebook","author":"Dobbins","year":"2017"},{"key":"10.1016\/j.msard.2024.105943_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s13760-013-0210-x","article-title":"Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures","volume":"113","author":"Durmus","year":"2013","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2024.105943_bib0026","article-title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study","volume":"7","author":"Egger","year":"2003","journal-title":"Health Technol. Assess. (Rockv)"},{"key":"10.1016\/j.msard.2024.105943_bib0027","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000444019","article-title":"Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review","volume":"46","author":"Eskandarieh","year":"2016","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0028","doi-asserted-by":"crossref","first-page":"102336","DOI":"10.1016\/j.msard.2020.102336","article-title":"Metabolic syndrome components and disease disability in Egyptian multiple sclerosis patients","volume":"44","author":"Fahmi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0029","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1590\/S0004-282X2009000600021","article-title":"Clinical features of multiple sclerosis in the south of Brazil: a partial analysis","volume":"67","author":"Finkelsztejn","year":"2009","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2024.105943_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11080964","article-title":"Death anxiety and attitudes towards death in patients with multiple sclerosis: an exploratory study","volume":"11","author":"Francalancia","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2024.105943_bib0091","article-title":"The impact of comorbidities on outcomes in the multiple sclerosis population: a rapid review protocol","author":"Frank","year":"2023","journal-title":"PROTOCOL (Version 1) available at Protocol Exchange"},{"key":"10.1016\/j.msard.2024.105943_bib0031","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3109\/09638288.2012.667503","article-title":"Factors affecting anxiety in multiple sclerosis","volume":"34","author":"Garfield","year":"2012","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.msard.2024.105943_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.msard.2024.105943_bib0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1176\/appi.neuropsych.18010011","article-title":"Depressive symptoms are associated with more negative functional outcomes than anxiety symptoms in persons with multiple sclerosis","volume":"31","author":"Gill","year":"2019","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.msard.2024.105943_bib0034","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1038\/s41598-022-23088-x","article-title":"Patient's perspective in clinical practice to assess and predict disability in multiple sclerosis","volume":"12","author":"Gil-Perotin","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2024.105943_bib0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000337162","article-title":"Therapeutic armamentarium and health system coverage of multiple sclerosis in Latin America","volume":"38","author":"Gracia","year":"2012","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0036","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/13524585211046739","article-title":"Epilepsy as a predictor of disease progression in multiple sclerosis","volume":"28","author":"Grothe","year":"2022","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2024.105943_bib0037","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00406-007-0759-6","article-title":"Neuropsychological deficits but not coping strategies are related to physical disability in multiple sclerosis","volume":"258","author":"Haase","year":"2008","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.msard.2024.105943_bib0038","first-page":"531","article-title":"Multiple Sclerosis Related Headaches","volume":"56","author":"Hamdy","year":"2009","journal-title":"egypt. j. psychiatry Neurosurg."},{"key":"10.1016\/j.msard.2024.105943_bib0039","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5604\/01.3001.0016.3323","article-title":"A study into the relationship between anxiety-depression and self-esteem disorder in patients with multiple sclerosis at the Rabat Ibn Sina Hospital, Morocco","volume":"21","author":"Harchaoui","year":"2023","journal-title":"Acta Neuropsychologica"},{"key":"10.1016\/j.msard.2024.105943_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s41983-023-00702-x","article-title":"Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants","volume":"59","author":"Hassan","year":"2023","journal-title":"Egypt. J. Neurol., Psychiatry Neurosurg."},{"key":"10.1016\/j.msard.2024.105943_bib0041","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1007\/s00415-020-10107-y","article-title":"A global view of comorbidity in multiple sclerosis: A systematic review with a focus on regional differences, methodology, and clinical implications","volume":"268","author":"Hauer","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0042","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000311013","article-title":"Validation of a self-report comorbidity questionnaire for multiple sclerosis","volume":"35","author":"Horton","year":"2010","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0043","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1038\/s41598-023-34545-6","article-title":"Early depressive symptoms and disability accrual in multiple sclerosis: a UK MS register study","volume":"13","author":"Jacobs","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2024.105943_bib0044","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0045","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/1352458506070935","article-title":"Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study","volume":"12","author":"Janssens","year":"2006","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0046","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1007\/s00415-015-7796-2","article-title":"Epidemiology of multiple sclerosis: results from a large observational study in the UK","volume":"262","author":"Jick","year":"2015","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0047","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"New England J. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0048","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/1352458509103300","article-title":"Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis","volume":"15","author":"Kern","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0049","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10194-010-0237-9","article-title":"Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course","volume":"11","author":"Kister","year":"2010","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.msard.2024.105943_bib0050","first-page":"29","article-title":"Comparison of the physical and non-physical functioning between the patients with multiple sclerosis and healthy subjects","volume":"13","author":"Kitis","year":"2008","journal-title":"Neurosciences"},{"key":"10.1016\/j.msard.2024.105943_bib0051","article-title":"Rapid reviews methods series: guidance on literature search","volume":"0","author":"Klerings","year":"2023","journal-title":"BMJ Evid.-Based Med. Month"},{"key":"10.1016\/j.msard.2024.105943_bib0052","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1468-1331.2008.02432.x","article-title":"Depression and disability accumulation in multiple sclerosis: a cross-sectional study","volume":"16","author":"Koch","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0053","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1177\/1352458508088937","article-title":"Depression and progression in multiple sclerosis","volume":"14","author":"Koch","year":"2008","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0054","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.esxm.2018.11.003","article-title":"Female sexual dysfunction among greek women with multiple sclerosis: correlations with organic and psychological factors","volume":"7","author":"Konstantinidis","year":"2019","journal-title":"Sex. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0055","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.msard.2013.06.006","article-title":"Neurological comorbidity and survival in multiple sclerosis","volume":"3","author":"Krokki","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0057","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1212\/WNL.0000000000004686","article-title":"Assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study","volume":"89","author":"Laroni","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0058","first-page":"1","article-title":"Brainstem lesions are associated with sleep apnea in multiple sclerosis","volume":"6","author":"Levit","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2024.105943_bib0059","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1111\/ene.14887","article-title":"Comorbidity patterns in people with multiple sclerosis: a latent class analysis of the Australian Multiple Sclerosis Longitudinal Study","volume":"28","author":"Lo","year":"2021","journal-title":"Euro J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0060","first-page":"301","article-title":"Patient-reported outcome measures reflect multiple sclerosis-related disability","volume":"27","author":"London","year":"2021","journal-title":"Multiple Sclerosis J."},{"key":"10.1016\/j.msard.2024.105943_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102724","article-title":"Disability measurement in Multiple Sclerosis patients 55 years and older: what is the Expanded Disability Status Scale really telling clinicians?","volume":"49","author":"Lynch","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101497","article-title":"Prognostic impact of epilepsy in multiple sclerosis","volume":"38","author":"Mahamud","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0063","first-page":"214","article-title":"The contribution of self-disclosure to the prediction of mood symptoms in patients with multiple sclerosis","volume":"20","author":"Mahboobi","year":"2021","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0064","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13760-015-0547-4","article-title":"The determinants of depression in a romanian cohort of multiple sclerosis patients","volume":"116","author":"Maier","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2024.105943_bib0065","doi-asserted-by":"crossref","first-page":"101997","DOI":"10.1016\/j.msard.2020.101997","article-title":"Restless legs syndrome among multiple sclerosis patients in Lebanon","volume":"41","author":"Makhoul","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0066","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1468-1331.2007.01740.x","article-title":"High prevalence of restless legs syndrome in multiple sclerosis","volume":"14","author":"Manconi","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0067","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp-2015-310361","article-title":"Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios","volume":"87","author":"Manouchehrinia","year":"2016","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2024.105943_bib0068","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148573","article-title":"Prevalence of comorbidities, overweight and obesity in an international sample of people with multiple sclerosis and associations with modifiable lifestyle factors","volume":"11","author":"Marck","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2024.105943_bib0069","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ane.13516","article-title":"Impact of comorbidities on the disability progression in multiple sclerosis","volume":"145","author":"Maric","year":"2022","journal-title":"Acta Neuro Scandinavica"},{"key":"10.1016\/j.msard.2024.105943_bib0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0071","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105943_bib0072","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","article-title":"Effect of comorbidity on mortality in multiple sclerosis","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.105943_bib0073","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1197195","article-title":"effects and management of comorbidities in multiple sclerosis: Recent advances","volume":"14","author":"Marrie","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2024.105943_bib0074","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","article-title":"Cumulative impact of comorbidity on quality of life in MS: comorbidity and quality of life in MS","volume":"125","author":"Marrie","year":"2012","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2024.105943_bib0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","article-title":"Comorbidity delays diagnosis and increases disability at diagnosis in MS","volume":"72","author":"Marrie","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0076","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0077","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/1352458514564485","article-title":"A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105943_bib0078","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0079","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.genhosppsych.2018.06.001","article-title":"Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases","volume":"53","author":"Marrie","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.msard.2024.105943_bib0080","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/1352458512437814","article-title":"Rising prevalence of vascular comorbidities in multiple sclerosis: Validation of administrative definitions for diabetes, hypertension, and hyperlipidemia","volume":"18","author":"Marrie","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105943_bib0081","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000343188","article-title":"The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study","volume":"40","author":"Marrie","year":"2013","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0082","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0083","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1177\/1352458515599073","article-title":"Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: a prospective multisite study","volume":"22","author":"McKay","year":"2016","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0084","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis","volume":"90","author":"McKay","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0086","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"10.1016\/j.msard.2024.105943_bib0087","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1590\/S0100-879X2008001000017","article-title":"Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients","volume":"41","author":"Moreira","year":"2008","journal-title":"Brazil. J. Med. Biol. Res."},{"key":"10.1016\/j.msard.2024.105943_bib0088","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.neuropsych.15070167","article-title":"Anxiety and depressive symptoms are associated with worse performance on objective cognitive tests in MS","volume":"28","author":"Morrow","year":"2016","journal-title":"J. Neuropsych. Clin. Neurosci."},{"key":"10.1016\/j.msard.2024.105943_bib0089","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s13311-017-0563-6","article-title":"Wellness and the role of comorbidities in multiple sclerosis","volume":"14","author":"Moss","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.msard.2024.105943_bib0090","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1468-1331.2007.01882.x","article-title":"Prevalence of autoimmune thyroid disorders in a Spanish multiple sclerosis cohort","volume":"14","author":"Munteis","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0092","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamaneurol.2015.4807","article-title":"Immunologic effects of metformin and pioglitazone treatment on metabolic syndrome and multiple sclerosis","volume":"73","author":"Negrotto","year":"2016","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0093","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-003-1053-9","article-title":"Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis","volume":"250","author":"Niederwieser","year":"2003","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0094","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2018.05.039","article-title":"Systematic review and meta-analysis of observational studies to understand the prevalence of restless legs syndrome in multiple sclerosis: An update","volume":"50","author":"Ning","year":"2018","journal-title":"Sleep. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0095","article-title":"Rapid reviews methods series: Guidance on team considerations, study selection, data extraction and risk of bias assessment","volume":"0","author":"Nussbaumer-Streit","year":"2023","journal-title":"BMJ Evid.-Based Med. Month"},{"key":"10.1016\/j.msard.2024.105943_bib0096","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nut.2013.08.001","article-title":"Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress","volume":"30","author":"Oliveira","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.msard.2024.105943_bib0097","first-page":"517","article-title":"Health-related quality of life in iranian patients with multiple sclerosis: a cross-cultural study","volume":"43","author":"Pakpour","year":"2009","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.msard.2024.105943_bib0098","doi-asserted-by":"crossref","first-page":"E1322","DOI":"10.1212\/WNL.0000000000012610","article-title":"Interface of multiple sclerosis, depression, vascular disease, and mortality: a population-based matched cohort study","volume":"97","author":"Palladino","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0099","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/1352458508099143","article-title":"Social anxiety in a multiple sclerosis clinic population","volume":"15","author":"Poder","year":"2009","journal-title":"Multiple Sclerosis"},{"key":"10.1016\/j.msard.2024.105943_bib0100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American academy of neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0101","doi-asserted-by":"crossref","first-page":"102850","DOI":"10.1016\/j.msard.2021.102850","article-title":"Psychometric properties of the croatian version of the depression, anxiety, and stress scale-21 and multiple sclerosis impact scale-29 in multiple sclerosis patients","volume":"50","author":"Rogi\u0107 Vidakovi\u0107","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0102","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000506161","article-title":"Risk of mortality in immigrants with multiple sclerosis in Ontario, Canada","volume":"54","author":"Rotstein","year":"2020","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0103","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clineuro.2016.01.017","article-title":"Headaches in multiple sclerosis: cross-sectional study of a multiethnic population","volume":"143","author":"Sahai-Srivastava","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105943_bib0104","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.4103\/0028-3886.349619","article-title":"Specifics of relationship within a complex of neurological deficit, quality of life and depression in the phenotypic spectrum of multiple sclerosis","volume":"70","author":"Sahakyan","year":"2022","journal-title":"Neurol. India"},{"key":"10.1016\/j.msard.2024.105943_bib0105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.msard.2018.12.015","article-title":"Risk of obstructive sleep apnea in multiple sclerosis: frequency, clinical and radiological correlates","volume":"28","author":"Salam","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0106","first-page":"397","article-title":"Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS","volume":"6","author":"Salter","year":"2016","journal-title":"Neurology: Clinical Practice"},{"key":"10.1016\/j.msard.2024.105943_bib0107","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1590\/0004-282x20200084","article-title":"Restless legs syndrome\/willis-ekbom disease in multiple sclerosis: a contributing factor for anxiety, disability, sleep disorder, and quality of life","volume":"78","author":"Sefero\u011flu","year":"2020","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2024.105943_bib0108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.20471\/may.2023.59.01.04","article-title":"Clinical and demographic determinants of cognitive disorders in multiple sclerosis patients","volume":"59","author":"\u0160ehanovi\u0107","year":"2023","journal-title":"Arch. Psych. Res."},{"key":"10.1016\/j.msard.2024.105943_bib0109","first-page":"30","article-title":"Affective models of depression and anxiety in patients with parkinson disease and multiple sclerosis","volume":"23","author":"\u0160ehanovi\u0107","year":"2022","journal-title":"Acta Medica Saliniana"},{"key":"10.1016\/j.msard.2024.105943_bib0110","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1111\/ene.15551","article-title":"Prognostic impact of epileptic seizures in multiple sclerosis varies according to time of occurrence and etiology","volume":"29","author":"Selton","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0111","first-page":"S189","article-title":"Restless legs syndrome in iranian multiple sclerosis patients: a case-control study","volume":"4","author":"Shaygannejad","year":"2013","journal-title":"Int. J. Prevent. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.sleep.2019.11.1266","volume":"70","author":"Shaygannejad","year":"2020","journal-title":"Sleep. Med."},{"key":"10.1016\/j.msard.2024.105943_bib0113","first-page":"1","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ (Online)"},{"key":"10.1016\/j.msard.2024.105943_bib0114","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4103\/0028-3886.170065","article-title":"Multiple sclerosis-Indian perspective","volume":"63","author":"Singhal","year":"2015","journal-title":"Neurol. India"},{"key":"10.1016\/j.msard.2024.105943_bib0115","series-title":"Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (with CD)","first-page":"12875","author":"Smedley","year":"2003"},{"key":"10.1016\/j.msard.2024.105943_bib0116","first-page":"1","article-title":"Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis","volume":"56","author":"Soliman","year":"2020","journal-title":"Egypt. J. Neurol., PsychiatryNeurosur."},{"key":"10.1016\/j.msard.2024.105943_bib0117","first-page":"299","article-title":"Restless legs syndrome\/Willis-Ekbom disease in multiple sclerosis patients with spinal cord lesions","volume":"57","author":"S\u00fcnter","year":"2020","journal-title":"Noropsikiyatri Arsivi"},{"key":"10.1016\/j.msard.2024.105943_bib0118","doi-asserted-by":"crossref","first-page":"106749","DOI":"10.1016\/j.clineuro.2021.106749","article-title":"Risk assessment of obstructive sleep apnea syndrome and other sleep disorders in multiple sclerosis patients","volume":"207","author":"Sunter","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2024.105943_bib0119","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000442203","article-title":"Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis","volume":"46","author":"Tettey","year":"2016","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2024.105943_bib0120","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","article-title":"Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality","volume":"89","author":"Thormann","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0121","doi-asserted-by":"crossref","first-page":"E1641","DOI":"10.1212\/WNL.0000000000012726","article-title":"Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome","volume":"97","author":"Tintore","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0122","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0042-1755233","article-title":"Sleep disorders in multiple sclerosis: a case-control study using the sao paulo epidemiologic sleep study (episono) database","volume":"80","author":"Toscano","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2024.105943_bib0123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0404.2006.00736.x","article-title":"Associations of the expanded disability status scale with anxiety and depression in multiple sclerosis outpatients","volume":"115","author":"Tsivgoulis","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2024.105943_bib0124","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13651500701330825","article-title":"Mood and anxiety disorders in patients with multiple slerosis","volume":"12","author":"Uguz","year":"2008","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.msard.2024.105943_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/6738645","article-title":"The influence of depression and anxiety on neurological disability in multiple sclerosis patients","volume":"2020","author":"V\u01cec\u01cera","year":"2020","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2017.08.003","article-title":"Illness burden and physical outcomes associated with collaborative care in patients with comorbid depressive disorder in chronic medical conditions: a systematic review and meta-analysis","volume":"50","author":"van Eck van der Sluijs","year":"2018","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.msard.2024.105943_bib0127","unstructured":"Veritas Health Innovation. Covidence systematic review software 2024."},{"key":"10.1016\/j.msard.2024.105943_bib0128","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1526-4610.2012.02146.x","article-title":"The impact of interferon beta and natalizumab on comorbid migraine in multiple sclerosis","volume":"52","author":"Villani","year":"2012","journal-title":"Headache: J. Head Face Pain"},{"key":"10.1016\/j.msard.2024.105943_bib0129","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.105943_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102010","article-title":"Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis","volume":"41","author":"Wang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2024.105943_bib0131","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1445-2197.2008.04730.x","article-title":"Rapid versus full systematic reviews: validity in clinical practice?","volume":"78","author":"Watt","year":"2008","journal-title":"ANZ. J. Surg."},{"key":"10.1016\/j.msard.2024.105943_bib0132","unstructured":"Wells, G., Shea, B., O'Connell, D., Robertson, J., Peterson, J., Welch, V., Losos, M., & Tugwell, P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis."},{"key":"10.1016\/j.msard.2024.105943_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.719088","article-title":"C-reactive protein levels and gadolinium-enhancing lesions are associated with the degree of depressive symptoms in newly diagnosed multiple sclerosis","volume":"12","author":"Yalachkov","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2024.105943_bib0134","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s11845-020-02377-2","article-title":"The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis","volume":"190","author":"Yigit","year":"2021","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.msard.2024.105943_bib0135","first-page":"1","article-title":"Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity","volume":"7","author":"Zhang","year":"2020","journal-title":"Neurology: Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2024.105943_bib0136","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2024.105943_bib0137","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1212\/WNL.0000000000004885","article-title":"Effects of physical comorbidities on disability progression in multiple sclerosis","volume":"90","author":"Zhang","year":"2018","journal-title":"Neurology"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:42:23Z","timestamp":1762602143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":137,"alternative-id":["S2211034824005194"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.105943","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.105943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105943"}}